JP7009444B2 - 抗菌性組成物 - Google Patents
抗菌性組成物 Download PDFInfo
- Publication number
- JP7009444B2 JP7009444B2 JP2019505417A JP2019505417A JP7009444B2 JP 7009444 B2 JP7009444 B2 JP 7009444B2 JP 2019505417 A JP2019505417 A JP 2019505417A JP 2019505417 A JP2019505417 A JP 2019505417A JP 7009444 B2 JP7009444 B2 JP 7009444B2
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- present
- compositions
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 122
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 30
- 150000001875 compounds Chemical class 0.000 claims description 34
- VVOAZFWZEDHOOU-UHFFFAOYSA-N honokiol Natural products OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 claims description 33
- 229940043810 zinc pyrithione Drugs 0.000 claims description 31
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical group [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims description 31
- 230000001476 alcoholic effect Effects 0.000 claims description 24
- 239000004094 surface-active agent Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000002453 shampoo Substances 0.000 claims description 14
- 230000003750 conditioning effect Effects 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- 229910052751 metal Inorganic materials 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 12
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 claims description 11
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 claims description 11
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 claims description 10
- FGVVTMRZYROCTH-UHFFFAOYSA-N pyridine-2-thiol N-oxide Chemical compound [O-][N+]1=CC=CC=C1S FGVVTMRZYROCTH-UHFFFAOYSA-N 0.000 claims description 10
- 229960002026 pyrithione Drugs 0.000 claims description 10
- 210000004761 scalp Anatomy 0.000 claims description 10
- 241000555688 Malassezia furfur Species 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 230000002195 synergetic effect Effects 0.000 description 20
- -1 scrubs Substances 0.000 description 19
- 239000004480 active ingredient Substances 0.000 description 16
- 239000000284 extract Substances 0.000 description 16
- 208000001840 Dandruff Diseases 0.000 description 13
- 239000003093 cationic surfactant Substances 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- 150000002191 fatty alcohols Chemical class 0.000 description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 6
- 229960005265 selenium sulfide Drugs 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000000375 suspending agent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 5
- 125000000129 anionic group Chemical group 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 241000218378 Magnolia Species 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 229920006317 cationic polymer Polymers 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 150000003752 zinc compounds Chemical class 0.000 description 4
- JHDBMHFWQRTXLV-UHFFFAOYSA-N 1-dodecoxydodecane;2-sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC JHDBMHFWQRTXLV-UHFFFAOYSA-N 0.000 description 3
- 244000303965 Cyamopsis psoralioides Species 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 3
- 230000000855 fungicidal effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000555676 Malassezia Species 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000005396 acrylic acid ester group Chemical group 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 229920013822 aminosilicone Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940059958 centella asiatica extract Drugs 0.000 description 2
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960003344 climbazole Drugs 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 2
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical group CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- VOHCMATXIKWIKC-UHFFFAOYSA-N 1-hydroxypyridine-2-thione;zinc Chemical compound [Zn].ON1C=CC=CC1=S VOHCMATXIKWIKC-UHFFFAOYSA-N 0.000 description 1
- BTMZHHCFEOXAAN-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;2-dodecylbenzenesulfonic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O BTMZHHCFEOXAAN-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000015700 Artemisia abrotanum Nutrition 0.000 description 1
- 244000249062 Artemisia abrotanum Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- GWNPOFPPMXKCLS-UHFFFAOYSA-N CCN1C(S)=CC#CC1 Chemical compound CCN1C(S)=CC#CC1 GWNPOFPPMXKCLS-UHFFFAOYSA-N 0.000 description 1
- 229920013683 Celanese Polymers 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000001938 Citrus medica Nutrition 0.000 description 1
- 241000723382 Corylus Species 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 241001098499 Lanceolata Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- ZWXYEWJNBYQXLK-UHFFFAOYSA-N azanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O ZWXYEWJNBYQXLK-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940075506 behentrimonium chloride Drugs 0.000 description 1
- TTZLKXKJIMOHHG-UHFFFAOYSA-M benzyl-decyl-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 TTZLKXKJIMOHHG-UHFFFAOYSA-M 0.000 description 1
- PXFDQFDPXWHEEP-UHFFFAOYSA-M benzyl-dimethyl-octylazanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)CC1=CC=CC=C1 PXFDQFDPXWHEEP-UHFFFAOYSA-M 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- WLCFKPHMRNPAFZ-UHFFFAOYSA-M didodecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC WLCFKPHMRNPAFZ-UHFFFAOYSA-M 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 150000002398 hexadecan-1-ols Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 235000020200 pasteurised milk Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- TVOIPJPTFTYKQM-UHFFFAOYSA-N propanedioic acid;zinc Chemical compound [Zn].OC(=O)CC(O)=O TVOIPJPTFTYKQM-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 229940032044 quaternium-18 Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- SFVFIFLLYFPGHH-UHFFFAOYSA-M stearalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SFVFIFLLYFPGHH-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
- 229940105956 tea-dodecylbenzenesulfonate Drugs 0.000 description 1
- 150000003512 tertiary amines Chemical group 0.000 description 1
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- AQZSPJRLCJSOED-UHFFFAOYSA-M trimethyl(octyl)azanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(C)C AQZSPJRLCJSOED-UHFFFAOYSA-M 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4933—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
(i)ピリチオンの多価金属塩、及び
(ii)0.1~10%の、ホノキオール、マグノロール又はペオノールから選択されるアルコール性化合物
を含む、相乗的抗菌性組成物が存在する。
ホノキオール
マグノロール
ペオノール
ホノキオールはSigma-Aldrich Co.LLC.から市販され、純度は98%以上である。この化合物は、世界の多くの地域で産する、マグノリア(Magnolia)属に属する樹木の種子錐及び葉から抽出されている。
本発明の特に好ましい態様として、組成物はシャンプーである。本発明の組成物、とりわけシャンプーは、アニオン性界面活性剤、例えばアルキルサルフェート及び/又はエトキシル化アルキルサルフェート界面活性剤と配合される。これらのアニオン性界面活性剤は、好ましくは、組成物の1~20重量%、好ましくは2~16重量%、さらに好ましくは3~16重量%の濃度で存在する。好ましいアルキルサルフェートは、C8-18アルキルサルフェート、より好ましくはC12-18アルキルサルフェートであり、好ましくはナトリウム、カリウム、アンモニウム又は置換アンモニウムなどの可溶性カチオンを有する塩の形態である。
式中、Rは8~18個(好ましくは12~18個)の炭素原子を有するアルキル又はアルケニルであり、nは少なくとも0.5を超える、好ましくは1~3、より好ましくは2~3の平均値を有する数であり、Mはナトリウム、カリウム、アンモニウム又は置換アンモニウムなどの可溶性カチオンである。一例はナトリウムラウリルエーテルサルフェート(SLES)である。平均エトキシル化度が0.5~3、好ましくは1~3であるSLESがとりわけ好ましい。
好ましくは、本発明の組成物は、懸濁化剤をさらに含む。好適な懸濁化剤は、ポリアクリル酸、アクリル酸の架橋ポリマー、アクリル酸と疎水性モノマーとのコポリマー、カルボン酸含有モノマーとアクリル系エステルのコポリマー、アクリル酸とアクリレートエステルの架橋コポリマー、ヘテロ多糖ガム及び結晶性長鎖アシル誘導体が挙げられる。長鎖アシル誘導体は、望ましくは、エチレングリコールステアレート、16~22個の炭素原子を有する脂肪酸のアルカノールアミド及びその混合物から選択される。エチレングリコールジステアレート及びポリエチレングリコール3ジステアレートは、組成物に真珠光沢を付与するので、好ましい長鎖アシル誘導体である。ポリアクリル酸は、カーボポール420、カーボポール488又はカーボポール493として市販されている。多官能剤で架橋されたアクリル酸のポリマーも使用することができ、それらはカーボポール910、カーボポール934、カーボポール941及びカーボポール980として市販されている。カルボン酸含有モノマーとアクリル酸エステルとの好適なコポリマーの例は、カーボポール1342である。すべてのカーボポール(商標)材料は、Goodrichから入手可能である。
コンディショニング効果が本発明の組成物によってもたらされる場合、その組成物はヘアコンディショナーと呼ばれる。通例、ヘアケア組成物に使用される最も一般的なコンディショニング剤は、非水溶性油状物質、例えば鉱油、天然油、例えばトリグリセリド及びシリコーンポリマーである。コンディショニング効果は、油性物質を頭髪に付着させることによって得られ、結果として皮膜が形成され、この皮膜により、頭髪は湿潤時にはより梳き易くなり、乾燥時にはより扱い易くなる。とりわけ有用なコンディショニング剤は、シリコーン化合物、好ましくは不揮発性シリコーン化合物である。有利には、本明細書の組成物は、1つ以上のシリコーンを含み得る。シリコーンは、分散又は懸濁した微粒子形態で見出されるコンディショニング剤である。シリコーンは、水で頭髪をすすいだ後に、頭髪に付着して残存するものである。好適なシリコーン油は、ポリアルキルシロキサン、ポリアリールシロキサン、ポリアルキルアリールシロキサン、ポリエーテルシロキサンコポリマー及びそれらの混合物を含み得る。アミノシリコーンは、シャンプー組成物に配合されることが多い。アミノシリコーンは、少なくとも1つの第1級アミン、第2級アミン、第3級アミン又は第4級アンモニウム基を含有するシリコーンである。高分子量シリコーンガムも利用することができる。別の有用な種類は、ジメチコーン/ビニル/ジメチコンクロスポリマー(例えばDow Corning 9040及び9041)などの架橋シリコーンエラストマーである。
本発明の組成物は、スキンケア、例えば身体又は顔の洗浄に使用され得る。抗菌性組成物は、界面活性剤をさらに含み得る。好ましい界面活性剤は非イオン性界面活性剤である。
実施例1~3:ZPTOと本発明のアルコール性化合物との間の相乗作用:
ZPTOとアルコール性化合物との間の相乗的相互作用を、ΣFICアッセイを用いて求めた。方法の簡単な説明を以下に示す。
微生物の調製:
MD寒天プレート(溶液A)に維持したM.フルフル(M.furfur)(CBS1878)を、20mlの増殖培地ピチロスポルム(Pityrosporum)ブロス(PB、溶液B)中で培養した。
改良Dixon寒天(MD)
麦芽エキス(Oxoid) 36g
真菌用ペプトン(Oxoid) 6g
精製寒天(Oxoid) 10
ウシ胆汁(Oxoid) 20g
オレイン酸(Sigma) 2ml
グリセロール(Sigma) 2ml
ツイン40(Sigma) 10ml
脱イオン水 1000mlまで
95%エタノール2mlに溶解させた、クロラムフェニコール(Oxoid SR078E)50mg(1バイアル)
(オートクレーブ後も含めて十分に攪拌すること)
溶液Bの調製
ピチロスポルム(Pityrosporum)ブロス(PB)
細菌用ペプトン 10g
酵母エキス 0.1g
ウシ胆汁 10g
タウロコール酸 2.5g
グルコース 10g
脱イオン水 1L
ツイン60 0.5ml
グリセロール 1ml
pHを6.2に調整
滅菌後
超高温殺菌牛乳 0.5ml
次にこれらを振盪しながら、32℃にて48時間インキュベートする。次いで、最初のブロス培養物1mlを新たなPB 9ml中に移し、振盪しながら32℃にて48時間インキュベートする。
ジンクピリチオンを段階希釈(2倍)して、増殖培地中2~125ppmの範囲で調製した。アルコール性化合物を段階希釈(2倍)して、増殖培地中10~10,000ppmの範囲で調製した。
アルコール性化合物濃度(ppm):1000、500、250、125、62.5、31.3、15.6、7.8、3.9、2.0、1.0及び0
プレートを32℃にて1日インキュベートした。次に、アラマーブルー(0.01%)20μlを各ウェルに添加し、さらに1日インキュベートして、色の変化を観察した。赤色は微生物の増殖を示し、変化のない青色は増殖がないことを示す。さらに、試験化合物単独では、微生物が添加されていない対照混合物によるアラマーブルーの色変化を引き起こさないことも確認された。
(1)最小阻害濃度(MIC):
MICは、試験条件下でアラマーブルーの青色によって示されるように、完全な微生物増殖阻害を与える、有効成分の絶対最低濃度として定義される。例えばジンクピリチオンでは、MICは1.6~3.2ppmと測定された。
単離物及び混合物における阻害性抗菌剤の異なる挙動は、部分濃度(FC)及び部分阻害濃度(FIC)の概念を使用して広く検討されてきた。パラメータは次のように定義できる。
MIC(単一有効成分として試験した成分a)
(3)相乗作用及び相加性
抗菌剤間の相互作用は、組合せの効力が、単独で試験した場合の個々の成分の同じ合計濃度に関して得られた効力に等しい、より大きい又はより小さいか否かによって、相加的、相乗作用的又は拮抗的であり得る。
ΣFIC=1は相加的殺菌活性に相当する。
実施例1~3で使用したものと同様の試験管内アッセイを使用して、ジンクピリチオンと、クリンバゾール及びセレンスルフィドなどの他の周知のフケ防止剤との間の相互作用が相乗作用を生じるか否かを判定する実験を行った。実験は、0~12.5ppmのジンクピリチオン濃度範囲にわたって行った。クリンバゾールは0~500ppmの濃度で変化させ、セレンスルフィドは0~100ppmの濃度で変化させた。
Claims (9)
- (i)ピリチオンの多価金属塩、及び
(ii)0.1~10%の、ホノキオール、マグノロール又はペオノールから選択されるアルコール性化合物
を含み、
マラセチア・フルフル(Malassezia furfur)の増殖を相乗的に阻害することを特徴とする、抗菌性組成物。 - 前記ピリチオンの多価金属塩がジンクピリチオンである、請求項1記載の組成物。
- 0.1~5.0%のピリチオン多価金属塩を含む、請求項1又は2に記載の組成物。
- 前記アルコール性化合物がマグノロールである、請求項1~3のいずれか一項に記載の組成物。
- 前記組成物が、水を含む化粧品的に許容される担体を含む、請求項1~4のいずれか一項に記載の組成物。
- 前記担体が界面活性剤をさらに含む、請求項5に記載の組成物。
- 前記組成物が洗い流しヘアケア組成物又はリーブオンヘアケア組成物である、請求項1~6のいずれか一項に記載の組成物。
- シャンプー又はヘアコンディショニング組成物である、請求項7に記載の組成物。
- 個人の頭皮に請求項1~8のいずれか一項に記載の組成物を適用するステップを含む、マラセチア・フルフル(Malassezia furfur)の増殖を阻害する方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016000471 | 2016-08-19 | ||
CNPCT/CN2016/000471 | 2016-08-19 | ||
EP16190028 | 2016-09-22 | ||
EP16190028.7 | 2016-09-22 | ||
PCT/EP2017/070316 WO2018033470A1 (en) | 2016-08-19 | 2017-08-10 | An antimicrobial composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019524778A JP2019524778A (ja) | 2019-09-05 |
JP7009444B2 true JP7009444B2 (ja) | 2022-01-25 |
Family
ID=59558416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019505417A Active JP7009444B2 (ja) | 2016-08-19 | 2017-08-10 | 抗菌性組成物 |
Country Status (7)
Country | Link |
---|---|
US (1) | US11246817B2 (ja) |
EP (1) | EP3500237B1 (ja) |
JP (1) | JP7009444B2 (ja) |
CN (1) | CN109640930B (ja) |
BR (1) | BR112019001868B1 (ja) |
MX (1) | MX378100B (ja) |
WO (1) | WO2018033470A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109640930B (zh) | 2016-08-19 | 2021-11-26 | 联合利华知识产权控股有限公司 | 抗微生物组合物 |
CN110604741A (zh) * | 2018-06-15 | 2019-12-24 | 瑞恩生化科技有限公司 | 抑制皮肤细胞增生的组合物及其应用 |
CN113616628A (zh) * | 2021-09-02 | 2021-11-09 | 南京泛成生物科技有限公司 | 丹皮酚对马拉色菌的抑制作用及其纳米乳的制备和应用 |
CN115227592B (zh) * | 2022-05-07 | 2024-07-19 | 彭氏(惠州)实业发展有限公司 | 抑菌剂组合物及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014131191A1 (en) | 2013-03-01 | 2014-09-04 | Johnson & Johnson Consumer Companies, Inc. | A composition containing honokiol and/or magnolol and uses thereof |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4185106A (en) | 1972-07-11 | 1980-01-22 | Hoechst Aktiengesellschaft | Pyridones as antidandruff agents |
US5045307A (en) | 1990-01-09 | 1991-09-03 | Colgate-Palmolive Company | Composition that protects dyed hair from fading |
JP2000504706A (ja) | 1996-02-16 | 2000-04-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗真菌薬及び硫黄化合物を含有する組成物 |
WO1998005294A1 (en) | 1996-08-02 | 1998-02-12 | Plum Kemi Produktion A/S | An oil-in-water emulsion for use on human skin for cleansing, preserving or improving the condition of the skin |
WO2000040207A1 (en) | 1999-01-04 | 2000-07-13 | The Procter & Gamble Company | Transparent hair conditioning composition comprising breakable visible particle |
AU2351300A (en) | 1999-12-02 | 2001-06-12 | Procter & Gamble Company, The | Conditioning shampoo compositions |
IL133760A (en) | 1999-12-28 | 2007-10-31 | Pharmaskin Ltd | Composition for the treatment of dandruff |
US6635702B1 (en) | 2000-04-11 | 2003-10-21 | Noveon Ip Holdings Corp. | Stable aqueous surfactant compositions |
US20020028754A1 (en) | 2000-07-21 | 2002-03-07 | Novozymes A/S | Antimicrobial compositions |
GB0028161D0 (en) | 2000-11-17 | 2001-01-03 | Natural Environment Res | Personal care compositions |
FR2816837A1 (fr) | 2000-11-17 | 2002-05-24 | Oreal | Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau |
GB2357968A (en) | 2000-12-18 | 2001-07-11 | Ciba Sc Holding Ag | Use of hydroxy diphenylethers as disinfectants |
JP2002193755A (ja) | 2000-12-28 | 2002-07-10 | Sansho Seiyaku Co Ltd | フケ・カユミ防止頭髪用および洗髪用化粧料 |
DE10111288A1 (de) | 2001-03-09 | 2002-09-12 | Wella Ag | Antischuppenmittel |
US20030161802A1 (en) | 2002-02-05 | 2003-08-28 | Flammer Linda J. | Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds |
US20030224028A1 (en) | 2002-05-13 | 2003-12-04 | Societe L'oreal S.A. | Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal |
WO2004006876A1 (en) | 2002-07-15 | 2004-01-22 | Unilever Plc | Hair and/or scalp treatment composition |
WO2004035012A1 (en) | 2002-10-18 | 2004-04-29 | Ciba Specialty Chemicals Holding Inc. | The use of biomimic polymers in personal care compositions |
CN1437925A (zh) | 2003-03-08 | 2003-08-27 | 梁栋 | 桉树叶水提液洗涤化妆品 |
US20040213751A1 (en) | 2003-03-18 | 2004-10-28 | Schwartz James Robert | Augmentation of pyrithione activity or a polyvalent metal salt of pyrithione activity by zinc-containing layered material |
JP4324494B2 (ja) | 2004-02-27 | 2009-09-02 | 花王株式会社 | 毛髪化粧料 |
US8338648B2 (en) | 2004-06-12 | 2012-12-25 | Signum Biosciences, Inc. | Topical compositions and methods for epithelial-related conditions |
US20080249136A1 (en) | 2005-10-25 | 2008-10-09 | Ioana Annis | Antimicrobial Composition and Method |
FR2894585B1 (fr) | 2005-12-14 | 2012-04-27 | Rhodia Recherches Et Tech | Copolymere comprenant des unites zwitterioniques et d'autres unites, composition comprenant le copolymere, et utilisation |
KR101446925B1 (ko) | 2006-02-24 | 2014-10-07 | 루브리졸 어드밴스드 머티어리얼스, 인코포레이티드 | 실리콘 코폴리올 마크로머를 함유하는 폴리머, 및 이를 함유하는 개인 관리 조성물 |
US7993630B2 (en) | 2007-02-17 | 2011-08-09 | Bioderm Research | Protection of skin from UV and peroxide |
DE102007009373A1 (de) | 2007-02-23 | 2008-08-28 | Henkel Ag & Co. Kgaa | Leistungsgesteigerte Haarbehandlungsmittel gegen Schuppen |
DE102007016708A1 (de) | 2007-04-04 | 2008-10-09 | Henkel Ag & Co. Kgaa | Stabilisierung tensidhaltiger Mittel |
BRPI0810435A2 (pt) | 2007-04-19 | 2014-11-25 | Mary Kay Inc | Composições contendo extrato de magnólia |
US20100272829A1 (en) | 2007-10-01 | 2010-10-28 | Yasuhiro Hidaka | Composition for transdermal or transmucosal administration |
WO2010139539A1 (de) | 2009-05-15 | 2010-12-09 | Basf Se | Pharmazeutische zusammensetzungen, enthaltend antifungale peptide |
DE102009048044A1 (de) | 2009-10-02 | 2011-04-21 | Beiersdorf Ag | Verwendung von Magnolol oder Honokiol als antibakterielle, antimycotische, antiparasitäre oder antivirale Wirkstoffe |
EP2664321B1 (en) | 2009-10-26 | 2018-08-22 | Nissan Chemical Industries, Ltd. | Medical instrument and preparation comprising a lipid peptide and gum arabic |
EP2515907A1 (en) | 2009-12-22 | 2012-10-31 | Deutsches Krebsforschungszentrum | Fluoroquinolones for the treatment and/or prophylaxis of inflammatory diseases |
CN102743363B (zh) | 2011-04-20 | 2015-01-21 | 上海邦氏生物科技有限公司 | 和厚朴酚及其衍生物制备治疗马拉色菌引起皮肤疾病的制品的用途 |
CN102218048B (zh) | 2011-04-21 | 2013-02-27 | 上海莱博生物科技有限公司 | 厚朴酚在制备治疗马拉色菌引起皮肤病的外用制剂和日化品中应用 |
US20160367091A9 (en) | 2011-06-13 | 2016-12-22 | Susana Fernandez Prieto | Personal Care Compositions Comprising a Di-Amido Gellant and Methods of Using |
CA2840215A1 (en) | 2011-06-22 | 2012-12-27 | Abhijit S. BAPAT | Conjugate-based antifungal and antibacterial prodrugs |
DE102011079539A1 (de) | 2011-07-21 | 2013-01-24 | Henkel Ag & Co. Kgaa | Leistungsgesteigerte Wirkstoffkombination und Haarbehandlungsmittel gegen Schuppen II |
CN104010525B (zh) | 2011-12-21 | 2017-08-25 | 默克专利股份有限公司 | 环己醇衍生物作为抗菌抗微生物活性物质的用途 |
JP6280047B2 (ja) | 2012-01-04 | 2018-02-14 | モメンティブ パフォーマンス マテリアルズ インコーポレイテッド | 末端官能化イオン性シリコーンを含有するパーソナルケア組成物 |
RU2014147075A (ru) | 2012-04-25 | 2016-06-10 | Мерк Патент Гмбх | Применение производных дициклогексилметанола с антимикробными свойствами |
WO2013167220A1 (de) | 2012-05-08 | 2013-11-14 | Merck Patent Gmbh | Verwendung von cyclohexanolethers mit antimikrobiellen eigenschaften |
FR2991688B1 (fr) | 2012-06-06 | 2015-05-22 | Soliance | Biosolubilisant |
ES2443088B1 (es) | 2012-07-16 | 2014-11-25 | Servicio Andaluz De Salud | Composicion y medios de cultivo que comprenden hialurona y un ácido graso esencial poliinsaturado seleccionado de entre ácido linoleico y ácido docosahexaenoico |
KR20140052576A (ko) * | 2012-10-25 | 2014-05-07 | 코웨이 주식회사 | 식물 발효 추출물을 포함하는 프리바이오틱 화장료 조성물 |
EP2774481B1 (en) | 2013-03-08 | 2018-06-13 | Symrise AG | Antimicrobial compositions |
EP2807925A1 (en) | 2013-05-26 | 2014-12-03 | Symrise AG | Antimicrobial compositions |
CN104225603A (zh) | 2013-06-18 | 2014-12-24 | 天津博克尼科技发展有限公司 | 丹皮酚甘油聚醚络合物 |
CN103655231B (zh) | 2013-07-03 | 2017-02-22 | 广州黛莱美化妆品有限公司 | 防受损洗发露 |
US20160317424A1 (en) | 2013-12-23 | 2016-11-03 | Lubrizol Advanced Materials, Inc. | Suspension and stability agent for antidandruff hair care compositions |
CN106456479A (zh) | 2014-05-21 | 2017-02-22 | 罗地亚经营管理公司 | 无硫酸盐的个人护理组合物 |
CN106572655A (zh) | 2014-06-27 | 2017-04-19 | 朱比兰特生命科学有限公司 | 吡啶硫酮锌的协同抗菌组合物 |
FR3024037B1 (fr) | 2014-07-25 | 2018-03-02 | Sederma | Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques |
GB201413216D0 (en) | 2014-07-25 | 2014-09-10 | Croda Internat Plc And Sederma Sas | Anti-Dandruff Composition |
CN105496890A (zh) * | 2015-12-31 | 2016-04-20 | 胡鹏 | 一种洗发护发盐及制备方法 |
MX378101B (es) | 2016-05-27 | 2025-03-10 | Unilever Ip Holdings B V | Una composicion limpiadora antimicrobiana |
MX375849B (es) | 2016-08-19 | 2025-03-07 | Unilever Ip Holdings B V | Una composicion antimicrobiana |
CN109640930B (zh) | 2016-08-19 | 2021-11-26 | 联合利华知识产权控股有限公司 | 抗微生物组合物 |
WO2018172121A1 (en) | 2017-03-23 | 2018-09-27 | Unilever N.V. | Hair care composition |
US20210228464A1 (en) | 2017-04-26 | 2021-07-29 | Conopco, Inc. D/B/A Unilever | Antidandruff hair care composition comprising pyrithione |
-
2017
- 2017-08-10 CN CN201780050921.0A patent/CN109640930B/zh active Active
- 2017-08-10 EP EP17749198.2A patent/EP3500237B1/en active Active
- 2017-08-10 BR BR112019001868-9A patent/BR112019001868B1/pt active IP Right Grant
- 2017-08-10 MX MX2019001788A patent/MX378100B/es unknown
- 2017-08-10 JP JP2019505417A patent/JP7009444B2/ja active Active
- 2017-08-10 WO PCT/EP2017/070316 patent/WO2018033470A1/en unknown
- 2017-08-10 US US16/323,630 patent/US11246817B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014131191A1 (en) | 2013-03-01 | 2014-09-04 | Johnson & Johnson Consumer Companies, Inc. | A composition containing honokiol and/or magnolol and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2018033470A1 (en) | 2018-02-22 |
BR112019001868A2 (pt) | 2019-05-07 |
US11246817B2 (en) | 2022-02-15 |
EP3500237A1 (en) | 2019-06-26 |
JP2019524778A (ja) | 2019-09-05 |
US20190201311A1 (en) | 2019-07-04 |
MX2019001788A (es) | 2019-06-13 |
EP3500237B1 (en) | 2020-11-25 |
MX378100B (es) | 2025-03-10 |
CN109640930A (zh) | 2019-04-16 |
CN109640930B (zh) | 2021-11-26 |
BR112019001868B1 (pt) | 2022-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7419465B2 (ja) | エッセンシャルオイルと抗菌性脂質とを含む抗菌性組成物 | |
JP6911100B2 (ja) | 抗菌性組成物 | |
JP7009444B2 (ja) | 抗菌性組成物 | |
EP3500234B1 (en) | An antimicrobial composition | |
CN109310596B (zh) | 抗微生物清洁组合物 | |
EP3612153B1 (en) | Antimicrobial composition for treating dandruff | |
RU2827411C1 (ru) | Композиция для местного применения, содержащая гидроксамовую кислоту и атрактиленолид | |
EP4007559B1 (en) | An antidandruff composition | |
WO2021254773A1 (en) | A topical antimicrobial composition | |
EA039964B1 (ru) | Противомикробная композиция, содержащая эфирное масло и противомикробный липид |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200610 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210427 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210511 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210806 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220112 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7009444 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |